Spotlight Therapeutics, a Bay Area biotech startup that aimed to “democratize” CRISPR gene editing for patients, has shut ...
" When you have women in leadership positions, cultures tend to become more inclusive, " Kawas observes. "These environments encourage team members to share opinions and take calculated risks." This ...
Recalls in the food and beverage industry due to contamination incidents can be catastrophic for a company. Not only do ...
As of Feb. 10, Johns Hopkins University in Baltimore has taken the most NIH funding so far in the current fiscal year ending Sept. 30, at $93.5 million spread across 191 grants.
CROPrime, a specialist in clinical trial site selection and feasibility, is offering its expertise to biotech and pharmaceutical companies seeking to collaborate with leading UK hospitals for their ...
The Philadelphia market has gained recognition not only for its cell and gene therapy sector but also its real estate scene and talent pool. Vittoria Biotherapeutics, Interius BioTherapeutics and ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Evaxion Biotech (EVAX – Research Report) and ...
Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.
Enacted in 2022, the Maryland Family and Medical Leave Insurance (FAMLI) program covers all employers with Maryland employees ...
Abhijit Naravane, a partner at PA Consulting, outlines strategies to help biopharma operations leaders successfully navigate the complexities of a product launch.
According to latest industry reports, the global Single-Use Bioprocessing Market is expected to expand significantly over the next decade, driven by increasing R&D activities, bio ...
The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results